3-Hydroxyphencyclidine (3-HPC), a breakdown product of phencyclidine (PCP), is increasingly attracting researcher scrutiny due to sparse data suggesting different pharmacological properties. Preliminary studies indicate that 3-HPC may possess independent responses on the nervous structure, arguably contributing to some of the unexpected reactions r